LDL-C target attainment and treatment costs in high-risk and very-high-risk patients with or without bempedoic acid: A Spanish cohort simulation

Juan Cosin-Sales, Maria Reyes Abad-Sazatornil, José Antonio Martín-Conde, Eder Alonso Iglesias, José Maria Mostaza Prieto · 2026

Read LDL-C target attainment and treatment costs in high-risk and very-high-risk patients with or without bempedoic acid: A Spanish cohort simulation by Juan Cosin-Sales, Maria Reyes Abad-Sazatornil, José Antonio Martín-Conde, Eder Alonso Iglesias, José Maria Mostaza Prieto (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0353193.txt.

Description

Juan Cosin-Sales and colleagues modelled cholesterol care for high-risk Spanish heart patients who stay above target on standard drugs. Their 2026 simulation used real records from nearly thirty-five thousand adults. It compared treatment paths that add bempedoic acid, a newer tablet, before moving to costly injections.

Adding the tablet brought about a third more patients to their cholesterol target. Later injections lifted control further still. Going straight to injections reached the same final control rates, but cost more. Placing bempedoic acid first cut yearly treatment costs by almost a third. The authors present that order as a way to protect health budgets without losing control of cholesterol.

Catalog record

CREATORJuan Cosin-Sales, Maria Reyes Abad-Sazatornil, José Antonio Martín-Conde, Eder Alonso Iglesias, José Maria Mostaza Prieto
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE35573
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0353193

Browse the full library · About the Tower of Babel